Detectiome is an AI-multiomics liquid biopsy blood test that can detect most cancers in stage 1 or 2 when they can be treated. It enables fast and economical development of precision diagnosis tailored for the local genetic background as the existing proven technology is developed with non-middle eastern population. The liquid biopsy early cancer detection using cell free DNA methylation is a promising new technique that identifies the cell free DNAs that come from cancer cells and use them for cancer screening and diagnosis.